Antimicrobial molecular nanocarrier-drug conjugates

Area of Science:

• Pharmaceutical Science
• Microbiology
• Nanotechnology

Background:

• Many antimicrobial drugs struggle against intracellular pathogens like Mycobacterium tuberculosis and Plasmodium falciparum.
• Limited cellular penetration hinders the effectiveness of existing antimicrobial agents.
• The inability of drugs to cross biological membranes is a key challenge in treating intracellular infections.

Purpose of the Study:

• To review the application of molecular organic nanocarriers in drug conjugation for enhanced antimicrobial therapy.
• To explore the potential of nanocarrier-drug conjugates in overcoming challenges of cellular penetration and intracellular targeting.
• To present the current status and future perspectives of nanocarrier-based antimicrobials.

Main Methods:

• Review of scientific literature on molecular organic nanocarriers and drug conjugation.
• Analysis of various nanocarrier types, including oligopeptides, carbon nanotubes, siderophores, dendrimers, terpenoids, and molecular umbrellas.
• Evaluation of the mechanism of action for nanocarrier-drug conjugates in penetrating cell membranes and delivering active agents.

Main Results:

• Molecular organic nanocarriers offer a promising strategy to improve drug delivery across biological membranes.
• Conjugation enables active agents to reach intracellular targets, either released or intact.
• Various nanocarriers demonstrate potential for developing novel antimicrobial agents.

Conclusions:

• Drug conjugation with molecular organic nanocarriers is a viable approach to enhance antimicrobial efficacy against intracellular pathogens.
• Nanocarrier-drug conjugates can overcome limitations of poor cellular penetration, improving treatment outcomes.
• Further research into nanocarrier design and drug conjugation holds significant promise for future antimicrobial therapies.